| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 12/11/2007 | US7307062 such as anxiety disorder, attention deficit/hyperactivity disorder, autistic disorder, bipolar disorder, major depression, mood disorder, pervasive developmental disorder, psychotic disorder and schizophrenia by administering an antimicrobial composition optionally with a probiotic mixture |
| 12/11/2007 | US7307057 Lantibiotics isolated from Microbispora sp. ATCC PTA-5024; activity against Gram-positive bacteria including methicillin and vancomycin resistant strains, and some Gram-negative bacteria such as M. catharralis, Neisseria species and H. influenzae and Mycobacteria. |
| 12/11/2007 | US7306938 High throughput screen for inhibitors of fatty acid biosynthesis in bacteria |
| 12/11/2007 | US7306808 Orientia tsutsugamushi truncated recombinant outer membrane protein (r47) and (r57) vaccines diagnostics and therapeutics for scrub typhus |
| 12/11/2007 | US7306804 HIV-specific T-cell induction |
| 12/11/2007 | US7306798 For AIDS and as a diagnostic tool or as a preventative and curative medicament; selectively binds the R7V epitope of the gp160 protein of the HIV-1 virus |
| 12/11/2007 | US7306783 Complexing; drug delivery; in situ imaging; detection apoptosis |
| 12/11/2007 | CA2393271C Retroviral protease inhibiting compounds |
| 12/11/2007 | CA2348735C Heterocyclic potassium channel inhibitors |
| 12/11/2007 | CA2259141C Treatment and diagnosis of infections of gram positive cocci |
| 12/11/2007 | CA2171618C Purine nucleoside phosphorylase gene therapy for human malignancy |
| 12/06/2007 | WO2007140254A2 Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors |
| 12/06/2007 | WO2007140109A1 Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors |
| 12/06/2007 | WO2007139968A2 Triazole compounds that modulate hsp90 activity |
| 12/06/2007 | WO2007139955A2 Triazole compounds that modulate hsp90 activity |
| 12/06/2007 | WO2007139729A1 Novel sulfonamidomethylphosphonate inhibitors of beta-lactamase |
| 12/06/2007 | WO2007139585A1 Controlled-release formulation |
| 12/06/2007 | WO2007139337A1 Composition and method for treating or preventing white spot syndrome virus |
| 12/06/2007 | WO2007139150A1 ANTI-INFLUENZA VIRAL AGENT COMPRISING TNF-α INHIBITOR |
| 12/06/2007 | WO2007139081A1 Anti-foot-and-mouth disease virus agent for animal belonging to family suidae or sheep, and method for prevention or treatment of foot-and-mouth disease in animal belonging to family suidae or sheep |
| 12/06/2007 | WO2007138999A1 Glycopeptide antibiotic derivative |
| 12/06/2007 | WO2007138994A1 Hsp90 inhibitor |
| 12/06/2007 | WO2007138974A1 Novel heterocyclic compound or salt thereof and intermediate thereof |
| 12/06/2007 | WO2007138781A1 Antiviral agent and antibacterial agent |
| 12/06/2007 | WO2007138242A1 Biphenyl derivatives and their use in treating hepatitis c |
| 12/06/2007 | WO2007138116A2 Pharmaceutical composition for the treatment of viral infections and/or tumor diseases by inhibiting protein folding and protein breakdown |
| 12/06/2007 | WO2007138047A2 Tri and tetra-oligo-saccharides suitable as agglutination agents for enteric pathogens |
| 12/06/2007 | WO2007137427A1 Bioactive purified hspe7 compositions |
| 12/06/2007 | WO2007137389A1 Use of compounds obtained from the neem tree (azadirachta indica) for the treatment of hiv/aids |
| 12/06/2007 | WO2007137386A1 Compositions and methods for the cure of hiv/aids |
| 12/06/2007 | WO2007118986A3 Concentrate of immunoglobulins and f(ab)'2 and/or fab fragments specific of an arbovirus as medicine |
| 12/06/2007 | WO2007117337A9 Development of novel antibiotic alternatives |
| 12/06/2007 | WO2007110834A3 Malate salts, and polymorphs of (3s,5s)-7-[3-amino-5-methyl-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid |
| 12/06/2007 | WO2007075872A3 Nitroimidazole compounds |
| 12/06/2007 | WO2007060518A3 Ketolide derivatives as antibacterial agents |
| 12/06/2007 | WO2007025187A3 Compounds and methods for modulating the silencing of a polynucleotide of interest |
| 12/06/2007 | WO2006106427A8 7-fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents |
| 12/06/2007 | WO2003023001A3 Novel proteins and nucleic acids encoding same |
| 12/06/2007 | US20070282105 e.g. 3-[2-(4-aminophenyl)ethyl]-8-benzyl-7-(2-ethylamino)ethyl-1-propylxanthine; A1-adenosine receptor antagonist; antiallergen, antiinflammatory agent; AIDS and immune deficiency disorders, asthma; good water solubility |
| 12/06/2007 | US20070282100 Boronic ester and acid compounds, synthesis and uses |
| 12/06/2007 | US20070282009 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
| 12/06/2007 | US20070282008 Antimicrobial Compositions and Methods for Their Use |
| 12/06/2007 | US20070281992 Combination of gyrase b inhibitors and protein synthesis inhibitors and uses thereof |
| 12/06/2007 | US20070281953 Substituted Dihydroquinazolines II |
| 12/06/2007 | US20070281947 Diarylmethylpiperazines As Prophylactic Or Therapeutic Agents For Viral Myocarditis |
| 12/06/2007 | US20070281938 Inhibitors of 11-Beta-Hydroxy Steroid Dehydrogenase Type 1 |
| 12/06/2007 | US20070281933 Novel Indazole Carboxamides And Their Use |
| 12/06/2007 | US20070281919 Aminothiazole Derivatives And Their Use As CRF Receptor Ligands |
| 12/06/2007 | US20070281916 Substituted isoxazolines and their use as antibacterial agents |
| 12/06/2007 | US20070281915 Porphyrin Derivatives and Their Use in Photodynamic Therapy |
| 12/06/2007 | US20070281904 Chitosan-derivative compounds and methods of controlling microbial populations |
| 12/06/2007 | US20070281897 By administering a cyclic di-GMP or a cyclic dinucleotide analogue; use as vaccine adjuvant |
| 12/06/2007 | US20070281070 Sterilization Solution and Method for Manufacturing Sterilization Solution |
| 12/06/2007 | US20070281048 Coffee Cherry Compositions and Methods |
| 12/06/2007 | US20070280972 Adhesive solid gel-forming formulations for dermal drug delivery |
| 12/06/2007 | US20070280968 Live Attenuated Bacterial Vaccine |
| 12/06/2007 | US20070280964 Compositions and methods useful for modulating immunity, enhancing vaccine efficacy, decreasing morbidity associated with chronic FHV-1 infections, and preventing or treating conjunctivitis |
| 12/06/2007 | US20070280963 Method for Producing Non-Pathogenic Helper Virus-Free Preparations of Herpes Virus Amplicon Vectors, the Helper Virus and the Cells Used in this Method, the Corresponding Generic Tools, as Well as the Applications of These Non-Pathogenic Amplicon Vectors |
| 12/06/2007 | US20070280962 HBV core antigen particles with multiple immunogenic components attached via peptid ligands |
| 12/06/2007 | US20070280961 cDNA corresponding to the antigenome of nonsegmented negative strand RNA viruses and process for the production of such viruses |
| 12/06/2007 | US20070280956 Novel hepatitis C virus peptides and uses thereof |
| 12/06/2007 | US20070280937 Compositions and Methods for the Treatment and Diagnosis of Neoplastic and Infectious Diseases |
| 12/06/2007 | US20070280929 Adjuvant in the form of a lipid-modified nucleic acid |
| 12/06/2007 | US20070280910 Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions |
| 12/06/2007 | DE102006026464A1 Pharmazeutische Zusammensetzung zur Behandlung von Virusinfektionen und / oder Tumorerkrankungen durch Inhibition der Proteinfaltung und des Proteinabbaus A pharmaceutical composition for the treatment of viral infections and / or tumors by inhibition of protein folding and protein degradation |
| 12/06/2007 | DE102006025146A1 Peptide that modulates proteasome activity, e.g. for disease treatment, comprises a human protein sequence |
| 12/06/2007 | CA2654276A1 Pharmaceutical composition for treatment of viral infections and/or tumor diseases by inhibiting protein folding and protein degradation |
| 12/06/2007 | CA2653933A1 Anti-foot-and-mouth disease virus agent for animal belonging to family suidae or sheep, and method for prevention or treatment of foot-and-mouth disease in animal belonging to family suidae or sheep |
| 12/06/2007 | CA2653924A1 Biphenyl derivatives and their use in treating hepatitis c |
| 12/06/2007 | CA2653821A1 Controlled-release formulation |
| 12/06/2007 | CA2653474A1 Bioactive purified hspe7 compositions |
| 12/06/2007 | CA2653332A1 Triazole compounds that modulate hsp90 activity |
| 12/06/2007 | CA2653319A1 Hsp90 inhibitor |
| 12/06/2007 | CA2653222A1 Triazole compounds that modulate hsp90 activity |
| 12/06/2007 | CA2652869A1 Novel sulfonamidomethylphosphonate inhibitors of beta-lactamase |
| 12/06/2007 | CA2652735A1 Tri and tetra-oligo-saccharides suitable as agglutination agents for enteric pathogens |
| 12/06/2007 | CA2652506A1 Glycopeptide antibiotic derivative |
| 12/06/2007 | CA2652501A1 Novel heterocyclic compound or salt thereof and intermediate thereof |
| 12/06/2007 | CA2650514A1 Salts and crystal modifications thereof |
| 12/05/2007 | EP1862550A1 Assembly of wild-type and chimeric influenza virus-like particles (VLPs) |
| 12/05/2007 | EP1862472A2 Chlamydia protein, gene sequence and uses thereof |
| 12/05/2007 | EP1862471A2 Pharmacologically active antiviral peptides and methods of their use |
| 12/05/2007 | EP1862467A2 Polyene antibiotics, compositions containing said antibiotics, method and micro-organisms used to obtain same and applications thereof |
| 12/05/2007 | EP1862457A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 12/05/2007 | EP1862184A1 Pharmaceutical composition |
| 12/05/2007 | EP1862071A2 Sterilization solution and method for manufacturing sterilization solution |
| 12/05/2007 | EP1861424A2 Human monoclonal antibodies against hendra and pipah viruses |
| 12/05/2007 | EP1861423A1 Molecules and chimeric molecules thereof |
| 12/05/2007 | EP1861401A1 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
| 12/05/2007 | EP1861396A1 Tricyclic derivatives of azetidine and pyrrole with antibacterial activity |
| 12/05/2007 | EP1861393A2 Pyrrole derivatives as dna gyrase and topoisomerase inhibitors |
| 12/05/2007 | EP1861130A2 Device and method for treatment of dermatomycosis, and in particular onychomycosis |
| 12/05/2007 | EP1861124A2 Production of bioactive glycoproteins from inactive starting materials by conjugation with hydroxyalkylstarch |
| 12/05/2007 | EP1861117A2 Immunologically active compositions |
| 12/05/2007 | EP1861115A2 Semi-synthetic glycopeptides with antibiotic activity |
| 12/05/2007 | EP1861111A2 Methods and compositions for increasing the safety and efficacy of albumin-binding drugs |
| 12/05/2007 | EP1861110A1 Antibiotic combinations for providing total solution to the treatment of infections |
| 12/05/2007 | EP1861088A1 Medicament and treatment for herpes simplex |
| 12/05/2007 | EP1861085A1 Antiviral compositions and methods of use |
| 12/05/2007 | EP1860943A2 Novel method |